dihexa safety concerns hgf c-met cancer risk Frontiers Frontiers | The Function of
Frontiers The Function of the HGF c Met Axis in Hepatocellular Carcinoma What is dihexa, its mechanism of action via the HGF c Met pathway, and its safety and clinical use? Developing c MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Targeting c MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications PMC
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



